Related Experiment Video
Updated: Apr 15, 2026

Identification of Mouse and Human Antibody Repertoires by Next-Generation Sequencing
Published on: March 15, 2019
[Preparation and identification of the polyclonal antibody against human insulin-like growth factor 2 mRNA-binding
Wei Zhao1, Qingwen Xu2, Ying Yang3
1Department of Clinical Laboratory, China-Japan Friendship Hospital, Beijing 100029, China.
Objective:
To construct the prokaryotic expression vector of insulin-like growth factor 2 mRNA-binding protein 3 (IGF2BP3), express and purify IGF2BP3 protein in E.coli, and prepare the polyclonal antibody against IGF2BP3.
Methods:
The full open reading frame (ORF) of human IGF2BP3 was amplified by PCR, subcloned into pET-28a vector, and transformed into E.coli BL21(DE3), in which expression of the His-tagged IGF2BP3 protein was induced by IPTG. This protein was subsequently purified by Ni-NTA purification system, refolded by removal of urea from the solution. BALB/c mice were immunized with the purified IGF2BP3 protein to produce polyclonal antibody against IGF2BP3. The resulting anti-sera were further characterized by ELISA, Western blotting and immunohistochemistry.
Results:
IGF2BP3 gene we amplified was consistent with the sequence reported by GenBank. Prokaryotic expression vector pET-28a-IGF2BP3 was constructed. His-tagged IGF2BP3 protein was successfully expressed in BL21 (DE3) with relative molecular mass (Mr) about 70 000 after IPTG induction. After purified by Ni-NTA resin, the purity of the protein reached above 90%. After immunization, the titer of the IGF2BP3 mouse anti-serum was over 1:50 000 as determined by ELISA. Further, Western blotting and immunohistochemistry showed that the IGF2BP3 antibody could specifically recognize the target protein.
Conclusion:
The polyclonal antibody specifically recognizing IGF2BP3 has been successfully generated.
More Related Videos
13:21Chemically-blocked Antibody Microarray for Multiplexed High-throughput Profiling of Specific Protein Glycosylation in Complex Samples
Published on: May 4, 2012
11:10Antibody Binding Specificity for Kappa (Vκ) Light Chain-containing Human (IgM) Antibodies: Polysialic Acid (PSA) Attached to NCAM as a Case Study
Published on: June 29, 2016